CCC
ABBV icon

Chelsea Counsel Company’s AbbVie ABBV Stock Holding History

Chelsea Counsel Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Hold
114
– – 0.01% 157
2025
Q4 		$26K Hold
114
– – 0.01% 148
2025
Q3 		$26.4K Buy
+114
New +$23.2K 0.01% 154
2023
Q1 		– Sell
-80
Closed -$12.9K – 151
2022
Q4 		$12.9K Buy
+80
New +$12.3K 0.01% 144
2022
Q3 		– Sell
-1,700
Closed -$260K – 82
2022
Q2 		$260K Hold
1,700
– – 0.13% 87
2022
Q1 		$276K Hold
1,700
– – 0.12% 86
2021
Q4 		$230K Buy
+1,700
New +$201K 0.1% 93
2018
Q3 		– Sell
-2,280
Closed -$211K – 77
2018
Q2 		$211K Sell
2,280
-100
-4% -$9.77K 0.13% 74
2018
Q1 		$225K Hold
2,380
– – 0.14% 64
2017
Q4 		$230K Hold
2,380
– – 0.12% 75
2017
Q3 		$211K Sell
2,380
-800
-25% -$60.9K 0.11% 77
2017
Q2 		$231K Hold
3,180
– – 0.12% 74
2017
Q1 		$207K Sell
3,180
-831
-21% -$52.2K 0.11% 77
2016
Q4 		$251K Hold
4,011
– – 0.13% 80
2016
Q3 		$253K Sell
4,011
-751
-16% -$48.6K 0.13% 83
2016
Q2 		$295K Hold
4,762
– – 0.13% 85
2016
Q1 		$272K Hold
4,762
– – 0.09% 109
2015
Q4 		$282K Sell
4,762
-2,831
-37% -$163K 0.09% 115
2015
Q3 		$413K Sell
7,593
-1
-0% -$65 0.1% 101
2015
Q2 		$510K Buy
7,594
+1,363
+22% +$89K 0.11% 85
2015
Q1 		$365K Hold
6,231
– – 0.08% 99
2014
Q4 		$408K Buy
6,231
+415
+7% +$26.2K 0.08% 93
2014
Q3 		$336K Sell
5,816
-171,159
-97% -$9.5M 0.07% 100
2014
Q2 		$9.99M Buy
176,975
+1,500
+0.9% +$78.7K 1.95% 21
2014
Q1 		$9.02M Buy
175,475
+1,806
+1% +$91.3K 1.83% 22
2013
Q4 		$9.17M Sell
173,669
-9,243
-5% -$454K 2.17% 19
2013
Q3 		$8.18M Buy
182,912
+355
+0.2% +$15.7K 1.7% 25
2013
Q2 		$7.55M Buy
+182,557
New +$7.98M 1.98% 22

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chelsea Counsel Company's ABBV Position: Q1 2026 in Review

Chelsea Counsel Company held its AbbVie (ABBV) position steady in Q1 2026 at 114 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #157.

Chelsea Counsel Company first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. The position peaked at $9.99M in Q2 2014. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Chelsea Counsel Company held 114 shares of AbbVie worth $24.8K as of Q1 2026.
  • Chelsea Counsel Company left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.01% of Chelsea Counsel Company's portfolio in Q1 2026, its #157 holding.
  • Chelsea Counsel Company first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
  • Chelsea Counsel Company's AbbVie position peaked at $9.99M in Q2 2014.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.